Description of the blood test:

The TPHA test is a highly specific laboratory study used to detect antibodies against Treponema pallidum, the bacterium that causes syphilis. Unlike non-treponemal screening tests (like RPR or VDRL), the TPHA specifically identifies the body’s immune response to the unique antigens of the pathogen itself. These antibodies typically appear about 3 to 4 weeks after infection and usually persist for life, even after successful treatment. In clinical diagnostics, this test is considered a “confirmatory” tool, used to verify the presence of the infection after a positive screening result.

What does the analysis represent?

• Purpose: Qualitative or semi-quantitative detection of specific antibodies to Treponema pallidum.
• Primary application: Confirmation of syphilis diagnosis, differential diagnosis of positive screening tests, and long-term monitoring of infection history.
• Performance: Hemagglutination reaction or modern automated immunoassays of a venous blood sample.

Recommendations for the test (General)

• Time: Blood collection is recommended during the morning hours.
• Fasting: A food intake pause of 4–8 hours is preferred.
• Rest: Stay in a calm state for 15–30 minutes before the procedure.
• Important: Because TPHA antibodies often remain positive for many years after treatment, this test is not typically used to measure the effectiveness of therapy or to identify a new re-infection in a person who has previously been treated.

What can affect the results?

• Autoimmune factors: In rare cases, systemic diseases (like lupus) can cause a biological false-positive result, though TPHA is much more specific than screening tests.
• Early stage: If performed too soon after initial exposure, the test may be negative because the body hasn’t yet produced enough specific antibodies.

When to take the test?

• Recommendations: Prescribed to confirm a positive RPR/VDRL screening, during pregnancy planning, before blood donation, or when symptoms like painless sores (chancres) or unexplained skin rashes appear.
• Preparation: Standard preparation for serological tests; avoid alcohol 24 hours prior to the analysis.

How to interpret the results?

The interpretation of data is the exclusive responsibility of an infectious disease specialist, urologist, or dermatovenerologist. A positive TPHA result is a biological indicator of the body’s contact with Treponema pallidum but is not a standalone diagnosis of an active stage of the disease. The physician must correlate the TPHA titer with non-specific markers (like RPR) and clinical symptoms. Only an expert can determine whether the result indicates a current active infection requiring treatment or a “serological scar” from a past, successfully treated infection.

Possible further investigations

• RPR or VDRL (Non-treponemal tests): To assess the current activity of the infection and monitor treatment response.
• PCR (Treponema pallidum DNA): To detect the pathogen directly from primary sores.
• Consultation with a Urologist: For specialized assessment of reproductive system health and symptom management.
• Consultation with a Neurologist: To rule out or manage neurological involvement (neurosyphilis) in cases of long-term infection.

When does the next step make sense?

A positive TPHA result is a significant finding that requires a professional medical review. The next step is a consultation to establish the exact stage of the infection and to create a treatment or monitoring plan that ensures your long-term health and prevents transmission.

👉 If necessary, you can discuss the test results with our specialized — urologist (Doctors – TAMC).